CEO, MedTech Diagnostics — Europe Growth Leader

NLC Health Ventures; Utrecht; Hybrid; EUR 60,000 - 120,000; Full time

Benefits offered by this job

Equity compensation

Hybrid work model with travel to the U

Job summary

Persuasive BV in the Netherlands seeks a hands-on Chief Executive Officer to steer final development and first commercialization. The role combines strategic leadership, investor relations, and go-to-market execution, with the founding transition to a CTO taking over technology and IP.

This hybrid position involves regular travel to Utrecht, engagement with European partners and US expansion plans, and a fundraising focus to secure 1–2M in the next round.

Qualifications

• Demonstrated success raising from angels, corporate VCs, and grant or foundation sources in medtech or IVD, with an existing warm investor network in the Netherlands, Belgium, or Germany.
• Senior leadership experience in In‑Vitro‑Diagnostics / biomarker detection technology / clinical laboratory, ideally in a start‑up/scale‑up environment.
• Experience shaping go-to‑market strategies, pricing, and commercial models for innovative medical products.
• Experience and network in the Cardiology / Cardiovascular space preferred.
• Comfortable operating in a small, fast‑moving organization where the CEO leads from the front.
• Experience working across European markets; exposure to the US market is a strong plus.
• Strong commercial judgment, resilience, and decisiveness, with a motivation to improve outcomes for chest pain patients.

Responsibilities

• Select a business model from the available options and build a credible go-to-market plan for Europe, with potential US expansion.
• Align shareholders and position the company for strategic partnerships and growth.
• Sharpen commercial focus, pricing, positioning, and marketing.
• Work alongside the CTO.
• Strengthen and professionalise PERSUASIVE’s proposition for pitching to investors.
• Fully dedicated to fundraising activities.
• Evaluate available business model options, select the most commercially viable path, and develop a 12 to 24‑month execution plan covering go‑to‑market, pricing, and positioning for the European market with a view to US expansion.
• Secure €1 to 2M in the next funding round through active outreach to angels, corporate VCs, and strategic partners, building a credible financial narrative around the verification and validation timeline and commercialization milestones.
• Represent PERSUASIVE externally with clinicians, strategic partners, and investors, while preparing the company for first commercialization in Europe, including US expansion.
• Drive fundraising efforts by actively engaging with suitable investors and leveraging technical and commercial acumen.
• Identify and remove barriers to adoption by spending time with customers to understand clinical applications, key stakeholders, hospital budgeting, workflows, training, and usage challenges, and translating these insights into action.
• Lead and refocus a small team on execution by setting clear priorities, ownership, and accountability, and eliminating non‑essential activity.

Skills

Fundraising

Go-to-market strategy

Investor relations

Medtech / IVD domain knowledge

Leadership

Strategic partnerships

Job description

Persuasive BV in the Netherlands seeks a hands-on Chief Executive Officer to steer final development and first commercialization. The role combines strategic leadership, investor relations, and go-to-market execution, with the founding transition to a CTO taking over technology and IP.

This hybrid position involves regular travel to Utrecht, engagement with European partners and US expansion plans, and a fundraising focus to secure 1–2M in the next round.